Head-to-head · Cost-Efficiency Index
June Health vs TeleCareSpot
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
June Health
Cost-first shoppers who want not clearly differentiated from other entry-level GLP-1 telehealth storefronts; caution warranted given its newness.
Visit June HealthTeleCareSpot
Shoppers comparing headline monthly rates who are willing to call/email for the real dose-tier breakdown.
Visit TeleCareSpotThe verdict
June Health and TeleCareSpot tie on the Cost-Efficiency Index at 59/100, so neither wins outright on the numbers. For most shoppers we'd start with June Health (ranked #273, a hair above #277) — Cost-first shoppers who want not clearly differentiated from other entry-level GLP-1 telehealth storefronts; caution warranted given its newness. But TeleCareSpot is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs June Health.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | June Health | TeleCareSpot |
|---|---|---|
| Cost-Efficiency Index | 59/100 | 59/100 |
| Semaglutide / mo | $199/mo (compounded) | $299/mo (compounded) |
| Tirzepatide / mo | $199/mo (compounded) | $399/mo (compounded oral) |
| Semaglutide / yr (modeled) | $2,388 | $3,588 |
| Tirzepatide / yr (modeled) | $2,388 | $4,788 |
| Coverage | Coverage not published | 48 states |
| Oral / sublingual | Yes | Yes |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #273 | #277 |
June Health
59/100Where the value is
- Low advertised entry price ($199/mo)
- Claims licensed providers in all 50 states
- Real legal/policy pages present in the footer despite being a new site
The tradeoffs
- Very new operation -- domain reportedly registered only in May 2026
- No LegitScript badge or certification mention found anywhere on the site
TeleCareSpot
59/100Where the value is
- LegitScript verification badge displayed on-site
- Offers both injectable and oral tirzepatide options
- Serves nearly all US states (only AK, MS, NJ excluded)
The tradeoffs
- 'From' pricing with no dose-tier breakdown -- real cost at your prescribed dose is unclear upfront
- No medical director named anywhere on the site
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.